The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of an anti-FLT3 antibody (LY3012218) in patients with relapsed acute myeloid leukemia.
 
David Sanford
No Relationships to Disclose
 
William G. Blum
No Relationships to Disclose
 
Farhad Ravandi
No Relationships to Disclose
 
Rebecca B. Klisovic
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
Alison R. Walker
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Guido Marcucci
No Relationships to Disclose
 
William G. Wierda
No Relationships to Disclose
 
Susan P. Whitman
No Relationships to Disclose
 
Hagop M. Kantarjian
Research Funding - Amgen (Inst); ARIAD (Inst); Bristol-Myers Squibb (Inst); Delta-Fly Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Jorge E. Cortes
Consulting or Advisory Role - ARIAD; Astellas Pharma; Novartis
Research Funding - Ambit BioSciences; ARIAD; Arog; Astellas Pharma; ImClone Systems; Novartis